Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company OncoMed Pharmaceuticals Inc.
DescriptionBispecific antibody against delta-like 4 (DLL4) and vascular endothelial growth factor (VEGF)
Molecular Target Delta-like 4 (DLL4) ; Vascular endothelial growth factor (VEGF)
Mechanism of ActionBispecific antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today